Literature DB >> 25192718

Challenges in the multidisciplinary management of stage IV colon and rectal cancer.

Pompiliu Piso1, Dirk Arnold, Gabriel Glockzin.   

Abstract

Colorectal metastases still represent a challenge to all oncologists despite progresses achieved by improved resectability, systemic chemotherapy and targeted therapies. In particular in patients with oligo-metastases, the role of surgical resections has been redefined. Resection is the most effective treatment method for liver metastases performed with curative intent; however, primary rate of resectability is low. Several methods to increase resectability have been developed: conversion chemotherapy, portal vein embolization, two-stage resections, vascular reconstruction of the liver veins, combination of resection and intraoperative ablation. Liver resections can be performed at present with low mortality. Patients with isolated peritoneal metastases, no extra-abdominal disease, low volume tumor and complete surgical cytoreduction do benefit from surgery and hyperthermic intraperitoneal chemotherapy. Several national guidelines recommend multimodality treatment for highly selected patients. The management of stage IV colorectal cancer includes several disciplines with focus on resection. A multidisciplinary evaluation of all patients is of crucial importance to define the treatment sequence and individual strategies for each patient.

Entities:  

Keywords:  ALPPS; HIPEC; liver metastases; peritoneal carcinomatosis

Mesh:

Year:  2014        PMID: 25192718     DOI: 10.1586/17474124.2015.957273

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  5 in total

1.  Benefit of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with isolated peritoneal metastases from colorectal cancer.

Authors:  Pompiliu Piso; Kathrin Stierstorfer; Michael Gerken; Monika Klinkhammer-Schalke
Journal:  Int J Colorectal Dis       Date:  2018-08-21       Impact factor: 2.571

2.  Postoperative chemotherapy is associated with prognosis of stage IV colorectal cancer treated with preoperative chemotherapy/chemoradiotherapy and curative resection.

Authors:  Hiroaki Nozawa; Hirofumi Sonoda; Hiroaki Ishii; Shigenobu Emoto; Koji Murono; Manabu Kaneko; Kazuhito Sasaki; Takeshi Nishikawa; Yasutaka Shuno; Toshiaki Tanaka; Kazushige Kawai; Keisuke Hata; Soichiro Ishihara
Journal:  Int J Colorectal Dis       Date:  2019-12-05       Impact factor: 2.571

3.  "En bloc" caudate lobe and inferior vena cava resection following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal and liver metastasis of colorectal cancer.

Authors:  Patricia Sánchez-Velázquez; Nicolas Moosmann; Ingolf Töpel; Pompiliu Piso
Journal:  World J Gastroenterol       Date:  2016-12-14       Impact factor: 5.742

4.  Neoadjuvant chemotherapy and radiotherapy followed by resection/ablation in stage IV rectal cancer patients with potentially resectable metastases.

Authors:  Rongzhen Li; Qiaoxuan Wang; Bin Zhang; Weiwei Xiao; Yuanhong Gao; Yan Yuan; Weihao Xie; Xiaoxue Huang; Chengjing Zhou; Shu Zhang; Shaoqing Niu; Hui Chang; Dongni Chen; Huikai Miao; Zhi Fan Zeng
Journal:  BMC Cancer       Date:  2021-12-14       Impact factor: 4.430

5.  Comparison of four lymph node staging systems for predicting prognosis for stage IV rectum cancer.

Authors:  Lingyu Han; Shaobo Mo; Wenqiang Xiang; Qingguo Li; Renjie Wang; Ye Xu; Weixing Dai; Guoxiang Cai
Journal:  Ann Transl Med       Date:  2020-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.